Literature DB >> 25552649

Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.

Adijat A Adebola1, Theo Di Castri2, Chui-Zhen He2, Laura A Salvatierra2, Jian Zhao2, Kristy Brown2, Chyuan-Sheng Lin1, Howard J Worman3, Ronald K H Liem4.   

Abstract

Charcot-Marie-Tooth disease (CMT) is the most commonly inherited neurological disorder with a prevalence of 1 in 2500 people worldwide. Patients suffer from degeneration of the peripheral nerves that control sensory information of the foot/leg and hand/arm. Multiple mutations in the neurofilament light polypeptide gene, NEFL, cause CMT2E. Previous studies in transfected cells showed that expression of disease-associated neurofilament light chain variants results in abnormal intermediate filament networks associated with defects in axonal transport. We have now generated knock-in mice with two different point mutations in Nefl: P8R that has been reported in multiple families with variable age of onset and N98S that has been described as an early-onset, sporadic mutation in multiple individuals. Nefl(P8R/+) and Nefl(P8R/P8R) mice were indistinguishable from Nefl(+/+) in terms of behavioral phenotype. In contrast, Nefl(N98S/+) mice had a noticeable tremor, and most animals showed a hindlimb clasping phenotype. Immunohistochemical analysis revealed multiple inclusions in the cell bodies and proximal axons of spinal cord neurons, disorganized processes in the cerebellum and abnormal processes in the cerebral cortex and pons. Abnormal processes were observed as early as post-natal day 7. Electron microscopic analysis of sciatic nerves showed a reduction in the number of neurofilaments, an increase in the number of microtubules and a decrease in the axonal diameters. The Nefl(N98S/+) mice provide an excellent model to study the pathogenesis of CMT2E and should prove useful for testing potential therapies.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25552649      PMCID: PMC4380066          DOI: 10.1093/hmg/ddu736

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  33 in total

1.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.

Authors:  I V Mersiyanova; A V Perepelov; A V Polyakov; V F Sitnikov; E L Dadali; R B Oparin; A N Petrin; O V Evgrafov
Journal:  Am J Hum Genet       Date:  2000-06-07       Impact factor: 11.025

Review 2.  Disease mechanisms in inherited neuropathies.

Authors:  Ueli Suter; Steven S Scherer
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

3.  Peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons.

Authors:  Aidong Yuan; Takahiro Sasaki; Asok Kumar; Corrinne M Peterhoff; Mala V Rao; Ronald K Liem; Jean-Pierre Julien; Ralph A Nixon
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

4.  Identification of novel sequence variants in the neurofilament-light gene in a Japanese population: analysis of Charcot-Marie-Tooth disease patients and normal individuals.

Authors:  Tsuyoshi Yoshihara; Masahiko Yamamoto; Naoki Hattori; Ken-ichiro Misu; Keiko Mori; Haruki Koike; Gen Sobue
Journal:  J Peripher Nerv Syst       Date:  2002-12       Impact factor: 3.494

5.  Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation.

Authors:  Raul Perez-Olle; Conrad L Leung; Ronald K H Liem
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

6.  Peripherin-mediated death of motor neurons rescued by overexpression of neurofilament NF-H proteins.

Authors:  Jean-Martin Beaulieu; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

7.  Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E.

Authors:  G M Fabrizi; T Cavallaro; C Angiari; L Bertolasi; I Cabrini; M Ferrarini; N Rizzuto
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

8.  Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models.

Authors:  Raul Perez-Olle; Sidonie T Jones; Ronald K H Liem
Journal:  Hum Mol Genet       Date:  2004-07-28       Impact factor: 6.150

9.  Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.

Authors:  A Jordanova; P De Jonghe; C F Boerkoel; H Takashima; E De Vriendt; C Ceuterick; J-J Martin; I J Butler; P Mancias; S Ch Papasozomenos; D Terespolsky; L Potocki; C W Brown; M Shy; D A Rita; I Tournev; I Kremensky; J R Lupski; V Timmerman
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

10.  Reduced number of unmyelinated sensory axons in peripherin null mice.

Authors:  R C Larivière; M D Nguyen; A Ribeiro-da-Silva; J-P Julien
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

View more
  19 in total

1.  Exacerbation of Charcot-Marie-Tooth type 2E neuropathy following traumatic nerve injury.

Authors:  Eric Villalón; Jeffrey M Dale; Maria Jones; Hailian Shen; Michael L Garcia
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

2.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

3.  Muscle spindle alterations precede onset of sensorimotor deficits in Charcot-Marie-Tooth type 2E.

Authors:  E Villalón; M R Jones; C Sibigtroth; S J Zino; J M Dale; D S Landayan; H Shen; D D W Cornelison; M L Garcia
Journal:  Genes Brain Behav       Date:  2016-10-11       Impact factor: 3.449

4.  N98S mutation in NEFL gene is dominantly inherited with a phenotype of polyneuropathy and cerebellar atrophy.

Authors:  Yi Yang; Li-Qiang Gu; William B Burnette; Jun Li
Journal:  J Neurol Sci       Date:  2016-04-09       Impact factor: 3.181

5.  NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.

Authors:  José Berciano; Kristien Peeters; Antonio García; Tomás López-Alburquerque; Elena Gallardo; Arantxa Hernández-Fabián; Ana L Pelayo-Negro; Els De Vriendt; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

6.  Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease.

Authors:  Alejandro Horga; Matilde Laurà; Zane Jaunmuktane; Nivedita U Jerath; Michael A Gonzalez; James M Polke; Roy Poh; Julian C Blake; Yo-Tsen Liu; Sarah Wiethoff; Conceição Bettencourt; Michael Pt Lunn; Hadi Manji; Michael G Hanna; Henry Houlden; Sebastian Brandner; Stephan Züchner; Michael Shy; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-05-13       Impact factor: 10.154

Review 7.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

Review 8.  Neurofilaments: neurobiological foundations for biomarker applications.

Authors:  Arie R Gafson; Nicolas R Barthélemy; Pascale Bomont; Roxana O Carare; Heather D Durham; Jean-Pierre Julien; Jens Kuhle; David Leppert; Ralph A Nixon; Roy O Weller; Henrik Zetterberg; Paul M Matthews
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

9.  Cellular reprogramming and inherited peripheral neuropathies: perspectives and challenges.

Authors:  Mario A Saporta
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

10.  Metabolite profile of a mouse model of Charcot-Marie-Tooth type 2D neuropathy: implications for disease mechanisms and interventions.

Authors:  Preeti Bais; Kirk Beebe; Kathryn H Morelli; Meagan E Currie; Sara N Norberg; Alexei V Evsikov; Kathy E Miers; Kevin L Seburn; Velina Guergueltcheva; Ivo Kremensky; Albena Jordanova; Carol J Bult; Robert W Burgess
Journal:  Biol Open       Date:  2016-07-15       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.